Back to Search
GABRIELA SARDINAS BAHR M.D.
M.D.
Rheumatology Physician
NPI: 1922340611IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
R4665(TX)
Rheumatology PhysicianPrimary
Internal Medicine — Rheumatology
Code: 207RR0500X
33838(OK)R4665(TX)
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Education
UNIVERSITY CENTRAL DEL CARIBE ESCUELA DE MEDICINA
Class of 2013
Research & Publications (20)
The common mycobacterial antigens and their importance in the treatment of disease.
PMID 19355964·Curr Pharm Des·2009
6-review
Effect of muramyl peptides on mitochondrial respiration.
PMID 19076831·Clin Exp Immunol·2009
7-preclinical
Up-regulation of NOD1 and NOD2 through TLR4 and TNF-alpha in LPS-treated murine macrophages.
PMID 16757890·J Vet Med Sci·2006
7-preclinical
Differentially expressed genes in HIV-1-infected macrophages following treatment with the virus-suppressive immunomodulator murabutide.
PMID 14687943·Virus Res·2004
8-other
Non-specific immunotherapy of HIV-1 infection: potential use of the synthetic immunodulator murabutide.
PMID 12493780·J Antimicrob Chemother·2003
6-review
Discordant effects of interleukin-2 on viral and immune parameters in human immunodeficiency virus-1-infected monocyte-derived mature dendritic cells.
PMID 12699419·Clin Exp Immunol·2003
8-other
A novel cellular RNA helicase, RH116, differentially regulates cell growth, programmed cell death and human immunodeficiency virus type 1 replication.
PMID 14645903·J Gen Virol·2003
4-observational
A phase I study of a six-week cycle of immunotherapy with Murabutide in HIV-1 patients naive to antiretrovirals.
PMID 12824957·Med Sci Monit·2003
3-trial
Clinical and immunological effects of a 6 week immunotherapy cycle with murabutide in HIV-1 patients with unsuccessful long-term antiretroviral treatment.
PMID 12716777·J Antimicrob Chemother·2003
3-trial
The transcriptional response of human macrophages to murabutide reflects a spectrum of biological effects for the synthetic immunomodulator.
PMID 12067302·Clin Exp Immunol·2002
8-other
Clinical tolerance and immunologic effects after single or repeated administrations of the synthetic immunomodulator murabutide in HIV-1-infected patients.
PMID 12131566·J Acquir Immune Defic Syndr·2002
3-trial
Modulation of cellular and humoral immune responses to a multiepitopic HIV-1 DNA vaccine by interleukin-18 DNA immunization/viral protein boost.
PMID 11282190·Vaccine·2001
7-preclinical
Variations in serum IL-7 and 90K/Mac-2 binding protein (Mac-2 BP) levels analysed in cohorts of HIV-1 patients and correlated with clinical changes following antiretroviral therapy.
PMID 11703373·Clin Exp Immunol·2001
8-other
Clinical tolerance and profile of cytokine induction in healthy volunteers following the simultaneous administration of ifn-alpha and the synthetic immunomodulator murabutide.
PMID 11576459·J Interferon Cytokine Res·2001
3-trial
SS-56, a novel cellular target of autoantibody responses in Sjögren syndrome and systemic lupus erythematosus.
PMID 11560955·J Clin Invest·2001
8-other
Enhanced maturation and functional capacity of monocyte-derived immature dendritic cells by the synthetic immunomodulator Murabutide.
PMID 11529939·Immunology·2001
8-other
Macrophage stimulation with Murabutide, an HIV-suppressive muramyl peptide derivative, selectively activates extracellular signal-regulated kinases 1 and 2, C/EBPbeta and STAT1: role of CD14 and Toll-like receptors 2 and 4.
PMID 11449348·Eur J Immunol·2001
7-preclinical
Selective regulation of human immunodeficiency virus-infected CD4(+) lymphocytes by a synthetic immunomodulator leads to potent virus suppression in vitro and in hu-PBL-SCID mice.
PMID 11435574·J Virol·2001
7-preclinical
Interleukin-18 modulates immune responses induced by HIV-1 Nef DNA prime/protein boost vaccine.
PMID 10924791·Vaccine·2000
7-preclinical
Cytokine analysis at the single cell level and lymphoproliferative responses to mycobacterial antigens in HIV-1 patients with successful virologic response to potent antiretrovirals.
PMID 11202236·J Clin Immunol·2000
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 5 locations total
- Address
- 643 Interstate 45 S
Huntsville, TX 77340 - Phone
- (281) 975-1000
Locations (5)
Practice Location
643 Interstate 45 S, Huntsville, TX
(281) 975-1000
Practice Location
22751 PROFESSIONAL DR STE 140, KINGWOOD, TX
(281) 975-1000
Practice Location
8845 Six Pines Dr Ste 200, Shenandoah, TX
(281) 975-1000
Practice Location
135 Vision Park Blvd, Shenandoah, TX
(281) 975-1000
Practice Location
2255 E MOSSY OAKS RD STE 500, SPRING, TX
(281) 975-1000
Quick Facts
- NPI
- 1922340611
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 4
- Locations
- 5
- Years in Practice
- 13
- Publications
- 20
Are you this provider?
Claim Your Profile